Literature DB >> 33704765

Citrobacter rodentium Lysogenized with a Shiga Toxin-Producing Phage: A Murine Model for Shiga Toxin-Producing E. coli Infection.

Laurice J Flowers1,2,3, Shenglan Hu1,4, Anishma Shrestha1, Amanda J Martinot5, John M Leong1, Marcia S Osburne6.   

Abstract

Shiga toxin-producing E. coli (STEC) is a common foodborne pathogen in developed countries. STEC generates "attaching and effacing" (AE) lesions on colonic epithelium, characterized by effacement of microvilli and the formation of actin "pedestals" beneath intimately attached bacteria. In addition, STEC are lysogenized with a phage that, upon induction, can produce potent Shiga toxins (Stx), potentially leading to both hemorrhagic colitis and hemolytic uremic syndrome. Investigation of the pathogenesis of this disease has been challenging because STEC does not readily colonize conventional mice.Citrobacter rodentium (CR) is a related mouse pathogen that also generates AE lesions. Whereas CR does not produce Stx, a murine model for STEC utilizes CR lysogenized with an E. coli-derived Stx phage, generating CR(Φstx), which both colonizes conventional mice and readily gives rise to systemic disease. We present here key methods for the use of CR(Φstx) infection as a highly predictable murine model for infection and disease by STEC. Importantly, we detail CR(Φstx) inoculation by feeding, determination of pathogen colonization, production of phage and toxin, and assessment of intestinal and renal pathology. These methods provide a framework for studying STEC-mediated systemic disease that may aid in the development of efficacious therapeutics.

Entities:  

Keywords:  Citrobacter rodentium; Lysogeny; Mouse infection; Shiga toxin; Stx phage

Mesh:

Substances:

Year:  2021        PMID: 33704765     DOI: 10.1007/978-1-0716-1339-9_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  49 in total

Review 1.  Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis.

Authors:  A D O'Brien; V L Tesh; A Donohue-Rolfe; M P Jackson; S Olsnes; K Sandvig; A A Lindberg; G T Keusch
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

2.  Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization.

Authors:  Cory M Robinson; James F Sinclair; Michael J Smith; Alison D O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

Review 3.  Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.

Authors:  Stephen B Freedman; Jianling Xie; Madisen S Neufeld; William L Hamilton; Lisa Hartling; Phillip I Tarr; Alberto Nettel-Aguirre; Anderson Chuck; Bonita Lee; David Johnson; Gillian Currie; James Talbot; Jason Jiang; Jim Dickinson; Jim Kellner; Judy MacDonald; Larry Svenson; Linda Chui; Marie Louie; Martin Lavoie; Mohamed Eltorki; Otto Vanderkooi; Raymond Tellier; Samina Ali; Steven Drews; Tim Graham; Xiao-Li Pang
Journal:  Clin Infect Dis       Date:  2016-02-24       Impact factor: 9.079

Review 4.  A review on strategies for decreasing E. coli O157:H7 risk in animals.

Authors:  Pardis Saeedi; Maryam Yazdanparast; Elham Behzadi; Ali Hatef Salmanian; Seyed Latif Mousavi; Shahram Nazarian; Jafar Amani
Journal:  Microb Pathog       Date:  2017-01-03       Impact factor: 3.738

Review 5.  Shiga Toxin/Verocytotoxin-Producing Escherichia coli Infections: Practical Clinical Perspectives.

Authors:  T Keefe Davis; Nicole C A J Van De Kar; Phillip I Tarr
Journal:  Microbiol Spectr       Date:  2014-08

Review 6.  Pathogenesis of Shiga-toxin producing escherichia coli.

Authors:  Angela Melton-Celsa; Krystle Mohawk; Louise Teel; Alison O'Brien
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 7.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

8.  A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease.

Authors:  Tiffany R Keepers; Mitchell A Psotka; Lisa K Gross; Tom G Obrig
Journal:  J Am Soc Nephrol       Date:  2006-11-02       Impact factor: 10.121

Review 9.  Escherichia coli O157:H7.

Authors:  P S Mead; P M Griffin
Journal:  Lancet       Date:  1998-10-10       Impact factor: 79.321

Review 10.  Intimate host attachment: enteropathogenic and enterohaemorrhagic Escherichia coli.

Authors:  Yushuan Lai; Ilan Rosenshine; John M Leong; Gad Frankel
Journal:  Cell Microbiol       Date:  2013-09-03       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.